Abstract OBJECTIVE: To investigate influential factors for the tendency to medicate and medication compliance in children with attention deficit hyperactivity disorder (ADHD). METHODS: A total of 188 children aged from 5 to 16 years, who were initially diagnosed with ADHD according to DSM-IV criteria, were included in the study. They underwent symptom assessment and cognitive function test. The compliance of methylphenidate treatment was evaluated. RESULTS: Patients with better emotional state, and fewer oppositional and hyperactive behaviors and those who had a family history of psychiatric diseases and who obtained lower scores in the number cancellation test (NCT), were more prone to medication and/or exhibited better medication compliance. Logistic regression analysis showed that fewer oppositional and hyperactive behaviors and lower NCT scores were the predictive factors for a higher tendency to medicate, and a better emotional state was the predictive factor for better medication compliance. Patients of predominantly inattentive type were more prone to medication and showed better medication compliance, as compared with those of combined type. Gender, age and symptom severity were not associated with the tendency to medicate and/or medication compliance. CONCLUSIONS: There is a need to enhance medication compliance in children with ADHD who have hyperactive, impulsive and oppositional behaviors, and to improve their long-term social functions.
DING Kai-Jing,LIU Yun-Fen,KANG Chuan-Yuan et al. Influential factors for methylphenidate treatment compliance in children with attention deficit hyperactivity disorder[J]. CJCP, 2013, 15(5): 343-347.
DING Kai-Jing,LIU Yun-Fen,KANG Chuan-Yuan et al. Influential factors for methylphenidate treatment compliance in children with attention deficit hyperactivity disorder[J]. CJCP, 2013, 15(5): 343-347.
［1］Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis［J］. Am J Psychiatry, 2007, 164(6): 942-948.
［7］Zhang S, Faries DE, Vowles M, Michelson D. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument［J］. Int J Methods Psychiatr Res, 2005, 14(4): 186-201.
［9］Barkley RA, McMurray MB, Edelbrock CS, Robbins K. Side effects of methylphenidate in children with attention deficit hyperactivity disorder: a systemic, placebo-controlled evaluation［J］. Pediatrics, 1990, 86(2): 184-192.
［10］Matthys W, Cuperus JM, Van Engeland H. Deficient social problem-solving in boys with ODD/CD, with ADHD, and with both disorders［J］. J Am Acad Child Adolesc Psychiatry, 1999, 38(3):311-321.
［11］Barkley RA, Fischer M, Smallish L. Young adult follow-up of hyperactive children: antisocial activities and drug use［J］. J Child Psychol Psych Allied Discipl, 2004, 45(2): 195-211.
［13］Montoya A, Colom F, Ferrin M. Is psychoeducation for parents and teachers of children and adolescents with ADHD efficacious? A systematic literature review［J］. Eur Psych, 2011, 26(3): 166-175.
［15］DosReis S, Mychailyszyn MP, Evans-Lacko SE, Beltran A, Riley AW, Myers MA. The meaning of attention-deficit/hyperactivity disorder medication and parents′initiation and continuity of treatment for their child［J］. J Child Adolesc Psychopharmacol, 2009, 19(4): 377-383.
［16］McGuinness TM. Helping parents decide on ADHD treatment for their children［J］. J Psychosoc Nurs Ment Health Serv, 2008, 46(8): 23-27.
